Where to buy Gilteritinib through formal channels

Gilteritinib (Gilteritinib) is a targeted drug used to treat **FLT3 mutation-positive acute myeloid leukemia (AML) **. It is currently on the market in China, but has not yet been included in the medical insurance system. This means that it may be difficult to purchase giritinib in regular domestic hospitals, especially in some areas or when hospitals have limited inventory. Patients may need to make an appointment in advance or obtain the drug through specific channels. Despite this, the original drugs marketed in China still provide patients with legal medication options, but the price is relatively high and they need to be financially prepared.

In addition to domestic channels, patients can also obtain giritinib through regular overseas channels. In the international market, giritinib is divided into two types: original drug and generic drug. There are two main types of original drugs: the European version and the Hong Kong version. The Hong Kong version costs up to 100,000 yuan, which is expensive and puts a heavy burden on most patients. The advantage of original drugs is that their drug ingredients and quality are completely consistent with clinical trials, and their efficacy and safety are fully supported by clinical data.

In comparison, the prices of generic drugs sold overseas are relatively affordable, especially the Laotian version of giritinib, which costs only between one thousand and two thousand yuan per box. The ingredients of these generic drugs are basically the same as those of the original drugs, which can reduce the financial pressure on patients to a certain extent while ensuring the continuity of treatment. When choosing overseas generic drugs, patients should ensure that they purchase them through formal channels to avoid the risk of counterfeit drugs or unstable quality.

In actual operation, patients can obtain giritinib through formal channels such as international drug procurement platforms, overseas hospitals or designated pharmacies. At the same time, it is recommended that patients maintain communication with their domestic attending doctors when using overseas drugs, and regularly monitor blood indicators and drug efficacy to ensure drug safety and therapeutic effect. In short, choosing the appropriate purchasing channel and scientific management of medication are the keys to ensuring the smooth implementation of giritinib treatment.

Reference materials:https://www.drugs.com/